Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04633655 · ClinicalTrials.gov registry record

International CIPN Assessment and Validation Study

A clinical trial of Quality of Life and Chemotherapy-induced Peripheral Neuropathy, sponsored by University of Milano Bicocca.

Recruiting
Registry status
1,000
Enrollment target
20
Study locations

NCT04633655 is a study of Quality of Life and Chemotherapy-induced Peripheral Neuropathy that is actively recruiting participants, run by University of Milano Bicocca. The registered enrollment target is 1,000 participants, above the 443-participant average among 107 other Quality of Life trials with a reported enrollment target (126% higher). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04633655, a study of Quality of Life and Chemotherapy-induced Peripheral Neuropathy, is actively recruiting participants, sponsored by University of Milano Bicocca.

RECRUITING
Registry status
1,000 participants
Enrollment target
20
Study locations

Study Summary

This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.

Interventions

  • OTHER outcome measures for CIPN testing

Study Locations (20)

Other

  • Brain and Mind Center - Sydney
  • Dept. of Neurology, Medical University of Vienna - Vienna
  • International Centre for Diarrhoeal Disease Research - Dhaka
  • Clínica AMO - Salvador
  • The Ottawa Hospital - Ottawa
  • Aarhus University Hospital - Aarhus
  • Hôpital Percy - Clamart
  • CHU Dupuytren - Limoges
  • Center for Molecular Medicine - Cologne
  • University of Larissa - Larissa
  • "Saint Andrew's" State General Hospital - Pátrai

Alabama

  • Birmingham School of Nursing, University of Alabama - Birmingham

Georgia

  • Northside Hospital - Atlanta

Maryland

  • JHU - Baltimore

Michigan

  • University of Michigan School of Nursing - Ann Arbor

New York

  • Columbia University Irving Medical Center - New York

Ohio

  • Cancer Center/Wexner Medical Center - Ohio State Medical Oncology Division - Columbus

Pennsylvania

  • Dartmouth-Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2020-06-08
Est. Completion 2025-12-31

Sponsor

University of Milano Bicocca

3 total trials

What the Registry Record Tells You About NCT04633655

The ClinicalTrials.gov registry entry for NCT04633655 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 443-participant average among 107 other Quality of Life trials with a reported enrollment target (126% higher). The listed sponsor is University of Milano Bicocca, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which outcome measures for CIPN testing is the first listed.

NCT04633655 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Other, Alabama, Georgia.

Frequently Asked Questions

What is clinical trial NCT04633655 about?

NCT04633655 is a clinical study titled "International CIPN Assessment and Validation Study". This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.

What is the current status of trial NCT04633655?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2020-06-08. Estimated completion is 2025-12-31.

What conditions does trial NCT04633655 study?

This clinical trial studies the following conditions: Quality of Life, Chemotherapy-induced Peripheral Neuropathy.

What interventions are being tested in trial NCT04633655?

The interventions under investigation include: outcome measures for CIPN testing (OTHER).

Who is sponsoring clinical trial NCT04633655?

This trial is sponsored by University of Milano Bicocca, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04633655 being conducted?

This trial has 20 study locations across Alabama, Georgia, Maryland, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.